EBR Systems Says Number of Heart Pacing System Implants Doubled in Q4 2025; Shares Rise 7%

MT Newswires Live

Jan 12

EBR Systems (ASX:EBR) said that its WiSE heart pacing system was implanted in 18 commercial patients during the fourth quarter of 2025, doubling the number of implants from the third quarter, according to a Monday Australian bourse filing.

An additional nine purchase agreements were signed with target centers during the December 2025 quarter, the filing said.

During the period, four patients were enrolled in the WiSE system utilization and performance study, a prospective observational study designed to evaluate real-world outcomes for heart failure patients receiving the WiSE system using left ventricular endocardial pacing for cardiac resycnhronization therapy.

The study will follow more than 300 commercial patients across 50 centers over a five-year period.

Looking ahead, the company expects to report revenue of $870,000 to $935,000 for the fourth quarter and $1.5 million to $1.6 million for 2025.

EBR Systems' shares rose 7% in recent trading on Monday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2602560462"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2602560462\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2602560462?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 12:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602560462","market":"fut","top_or_hot":-1,"title":"EBR Systems Says Number of Heart Pacing System Implants Doubled in Q4 2025; Shares Rise 7%","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) said that its WiSE heart pacing system was implanted in 18 commercial patients during the fourth quarter of 2025, doubling the number of implants from the third quarter, according to a Monday Australian bourse filing.</p><p>An additional nine purchase agreements were signed with target centers during the December 2025 quarter, the filing said.</p><p>During the period, four patients were enrolled in the WiSE system utilization and performance study, a prospective observational study designed to evaluate real-world outcomes for heart failure patients receiving the WiSE system using left ventricular endocardial pacing for cardiac resycnhronization therapy.</p><p>The study will follow more than 300 commercial patients across 50 centers over a five-year period.</p><p>Looking ahead, the company expects to report revenue of $870,000 to $935,000 for the fourth quarter and $1.5 million to $1.6 million for 2025.</p><p>EBR Systems' shares rose 7% in recent trading on Monday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Systems Says Number of Heart Pacing System Implants Doubled in Q4 2025; Shares Rise 7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Systems Says Number of Heart Pacing System Implants Doubled in Q4 2025; Shares Rise 7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-12 12:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) said that its WiSE heart pacing system was implanted in 18 commercial patients during the fourth quarter of 2025, doubling the number of implants from the third quarter, according to a Monday Australian bourse filing.</p><p>An additional nine purchase agreements were signed with target centers during the December 2025 quarter, the filing said.</p><p>During the period, four patients were enrolled in the WiSE system utilization and performance study, a prospective observational study designed to evaluate real-world outcomes for heart failure patients receiving the WiSE system using left ventricular endocardial pacing for cardiac resycnhronization therapy.</p><p>The study will follow more than 300 commercial patients across 50 centers over a five-year period.</p><p>Looking ahead, the company expects to report revenue of $870,000 to $935,000 for the fourth quarter and $1.5 million to $1.6 million for 2025.</p><p>EBR Systems' shares rose 7% in recent trading on Monday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2602560462","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602560462","pubTimestamp":1768191579,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems  said that its WiSE heart pacing system was implanted in 18 commercial patients during the fourth quarter of 2025, doubling the number of implants from the third quarter, according to a Monday Australian bourse filing.An additional nine purchase agreements were signed with target centers during the December 2025 quarter, the filing said.During the period, four patients were enrolled in the WiSE system utilization and performance study, a prospective observational study designed to evaluate real-world outcomes for heart failure patients receiving the WiSE system using left ventricular endocardial pacing for cardiac resycnhronization therapy.The study will follow more than 300 commercial patients across 50 centers over a five-year period.Looking ahead, the company expects to report revenue of $870,000 to $935,000 for the fourth quarter and $1.5 million to $1.6 million for 2025.EBR Systems' shares rose 7% in recent trading on Monday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","EBR.AU":"EBR SYSTEMS INC-CDI"},"translate_title":"EBR Systems表示，2025年第四季度心脏起搏系统植入数量翻了一番；股价上涨7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR.AU":1},"content_text":"EBR Systems (ASX:EBR) said that its WiSE heart pacing system was implanted in 18 commercial patients during the fourth quarter of 2025, doubling the number of implants from the third quarter, according to a Monday Australian bourse filing.An additional nine purchase agreements were signed with target centers during the December 2025 quarter, the filing said.During the period, four patients were enrolled in the WiSE system utilization and performance study, a prospective observational study designed to evaluate real-world outcomes for heart failure patients receiving the WiSE system using left ventricular endocardial pacing for cardiac resycnhronization therapy.The study will follow more than 300 commercial patients across 50 centers over a five-year period.Looking ahead, the company expects to report revenue of $870,000 to $935,000 for the fourth quarter and $1.5 million to $1.6 million for 2025.EBR Systems' shares rose 7% in recent trading on Monday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}